A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility.
A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility.
复制标题
重组沙眼衣原体 MOMP 疫苗可对小鼠产生跨血清群保护,防止阴道脱落和不孕。
DOI:
10.1093/infdis/jiz438
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
delaMaza,LuisM
中科院分区:
文献类型:
--
作者:
Tifrea,DeliaF;Pal,Sukumar;delaMaza,LuisM
BackgroundChlamydia trachomatisis the most common sexually transmitted bacterial pathogen worldwide. Here, we determined the ability of aC. trachomatisrecombinant major outer membrane protein (rMOMP) vaccine to elicit cross-serogroup protection.MethodsFemale C3H/HeN mice were vaccinated by mucosal and systemic routes withC. trachomatisserovar D (UW-3/Cx) rMOMP and challenged in the ovarian bursa with serovars D (UW-3/Cx), D (UCI-96/Cx), E (IOL-43), or F (N.I.1). CpG-1826 and Montanide ISA 720 were used as adjuvants.ResultsImmune responses following vaccination were more robust against the most closely related serovars. Following a genital challenge (as determined by number of mice with positive vaginal cultures, number of positive cultures, number of inclusion forming units recovered, and number of days with positive cultures) mice challenged withC. trachomatisserovars of the same complex were protected but not those challenged with serovar F (N.I.1) from a different subcomplex. Females were caged with male mice. Based on fertility rates, number of embryos, and hydrosalpinx formation, vaccinated mice were protected against challenges with serovars D (UW-3/Cx), D (UCI-96/Cx), and E (IOL-43) but not F (N.I.1).ConclusionsThis is the first subunit vaccine shown to protect mice against infection, pathology, and infertility caused by differentC. trachomatisserovars.